Product
Supplier
Encyclopedia
Inquiry
3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1 buy - large image1
3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1 buy - image1

3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1

61 Inquiries

Unit Price:

$1/G EXW

Get Latest Price
CAS No.:

872511-34-7

Port:

shanghai

Packaging:

bag

Price valid (until):

2026-10-01

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Cosmetics raw materials,Pesticide intermediate,Photoelectric material,pharmaceutical intermediates,Raw materials for food and health products,Polymer materials

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    This product is a pharmaceutical intermediate and is intended solely for research purposes. It enjoys significant advantages in terms of being available in stock. The purity is 99%.

    Items Specifications






    ECHEMI Editorial Reference
    Infigratinib (BGJ-398) is a potent inhibitor of the FGFR family with IC50s of 0.9 nM, 1.4 nM, 1 nM, and 60 nM for FGFR1, FGFR2, FGFR3, and FGFR4, respectively.

    Basic Info
    Product Name:

    3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea

    Other Name:

    3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea;NVP-BGJ398;BGJ 398;BGJ-398;BGJ398 (NVP-BGJ398);3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea NVP-BGJ398;NVP-BGJ3983-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea;Urea, N'-(2,6-dichloro-3,5-dimethoxyphenyl)-N-[6-[[4-(4-ethyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]-N-methyl-, methanesulfonate

    CAS No.:

    872511-34-7

    Molecular Formula:

    C26H31Cl2N7O3

    InChIKeys:

    QADPYRIHXKWUSV-UHFFFAOYSA-N

    Molecular Weight:

    560.47544

    Exact Mass:

    559.186523

    Characteristics
    PSA:

    95.1

    XLogP3:

    4.7

    Density:

    1.4±0.1 g/cm3

    Boiling Point:

    747.9±60.0°C at 760 mmHg

    Flash Point:

    406.1±32.9 °C

    Refractive Index:

    1.654

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Cosmetics raw materials,Pesticide intermediate,Photoelectric material,pharmaceutical intermediates,Raw materials for food and health products,Polymer materials

    Location:

    D307, Zhuque Square Office Building, No. 14, Chang'an North Road, Beilin District, Xi'an City, Shaanxi Province

    Payment Terms:

    TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    45

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    11-50

    Year of Establishment:

    2023

    Certifications:

    ISO,ISO,ISO

    Shaanxi Cuikang Pharmaceutical Technology Co., Ltd., founded in January 2023, is a wholly-owned subsidiary of Shaanxi Cuicheng Bio-pharmaceutical Technology Co., Ltd., and a comprehensive innovative enterprise focusing on the research and development, production, sales, import and export trade, technical services and related resource allocation and integration of products in the field of fine chemistry and biochemistry. The company has built a 2700 square meter R&D center in Hanzhong, Shaanxi Province, and has established in-depth and stable cooperative relations with three factories, which can provide one-stop service for domestic and foreign customers from pilot R&D to industrial scale-up production.

    Cuikang Company is an enterprise integrating natural products, fine chemicals, biological fermentation, innovative material research and development, production, sales and technical services. It can provide global customers with a series of products with different specifications and models, such as proportional plant extracts, content plant extracts, synthetic chemical blocks, synthetic pharmaceutical intermediates, active API molecules, fermented pharmaceutical intermediates and APIs, health food, functional food raw materials, veterinary drug raw materials, pharmaceutical innovative materials, laboratory equipment, pharmaceutical machinery and equipment.

    The company adheres to the market demand-oriented, technical innovation as the starting point, product quality as the core, customer service as the foundation, and the enterprise spirit of "professional integrity", and wholeheartedly provides high-quality products and services for customers at home and abroad.


  • Inquiry History
    61 Inquiries
    Country Product Purchase Quantity Date Posted
    Indonesia

    infigratinib

    2 G Aug 30, 2026
    Canada

    Infigratinib

    1 G Aug 28, 2026
    United States

    High Quality Infigratinib 99% powder

    7 G Aug 8, 2026
    United States

    Infigratinib

    500 MG Jul 25, 2026
    Canada

    Infigratinib

    1 G Jul 14, 2026
    Cyprus

    infigratinib

    1 G Jul 13, 2026
    Canada

    Infigratinib

    1 G Jun 24, 2026
    Australia

    infigratinib

    2 G Jun 20, 2026
    United States

    Infigratinib 5G High Quality Shaanxi Dideu Medichem Co.Ltd

    2 G Jun 16, 2026
    United States

    Infigratinib 5G High Quality Shaanxi Dideu Medichem Co.Ltd

    2 G Jun 8, 2026
    United States

    Infigrantinib

    5 G Jun 4, 2026
    United States

    Infigratinib

    10 G Jun 3, 2026
    United States

    high quality infigratinib API raw powder

    1 MT May 26, 2026
    Colombia

    high quality Infigratinib API raw powder

    50 G May 22, 2026
    Australia

    BGJ398

    2 G May 20, 2026
    United Kingdom

    Infigratinib

    1 G Mar 31, 2026
    United States

    Infigratinib

    1 G Mar 25, 2026
    United States

    Infigratinib capsules

    50 G Feb 8, 2026
    Poland

    Infigratinib

    1 G Jan 31, 2026
    Poland

    Infigratinib

    1 G Jan 29, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.